Fed. Circ. Pushed To Revive $200M Boston Scientific IP Suit

Law360, Washington (August 11, 2017, 3:15 PM EDT) -- A California cardiologist claiming that Boston Scientific Corp. owes him more than $200 million in royalty payments for using his patented stent technology argued to a Federal Circuit panel Friday that a trial court improperly threw out a favorable infringement verdict under the rarely used “ensnarement” defense.

Counsel for David Jang told the three-judge panel that the California federal judge didn’t follow the proper analysis for an ensnarement defense when she overturned the inventor’s July 2015 verdict that Boston Scientific's Express stents infringed his patent under...
To view the full article, register now.

Related

Sections

Case Information

Case Title

Jang v. Boston Scientific Corporation


Case Number

16-1275

Court

Appellate - Federal Circuit

Nature of Suit

830 Patent Infringement (Fed. Question)

Date Filed

December 2, 2015

Law Firms

Companies

Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.